Akeso, Inc. (HKG:9926)
Hong Kong
· Delayed Price · Currency is HKD 124.10
+0.70 (0.57%)
At close: Dec 5, 2025
Akeso Market Cap
Akeso has a market cap or net worth of 114.31 billion as of December 5, 2025. Its market cap has increased by 88.54% in one year.
Market Cap
114.31B
Enterprise Value
111.38B
Revenue
2.75B
Ranking
n/a
PE Ratio
n/a
Stock Price
124.10
Market Cap Chart
Since April 24, 2020, Akeso's market cap has increased from 18.54B to 114.31B, an increase of 516.44%. That is a compound annual growth rate of 38.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 113.67B | 108.63% |
| Dec 31, 2024 | 54.48B | 39.61% |
| Dec 29, 2023 | 39.03B | 7.91% |
| Dec 30, 2022 | 36.17B | 30.19% |
| Dec 31, 2021 | 27.78B | -7.12% |
| Dec 31, 2020 | 29.91B | 61.28% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 285.39B |
| Hansoh Pharmaceutical Group Company | 244.94B |
| JD Health International | 192.57B |
| Innovent Biologics | 160.32B |
| WuXi Biologics | 135.64B |
| Sino Biopharmaceutical | 122.99B |
| Sichuan Kelun-Biotech Biopharmaceutical | 104.70B |
| Alibaba Health Information Technology | 88.74B |